Modulators of the urokinase-type plasminogen activation system for cancer
- 1 December 2000
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 10 (12) , 1843-1852
- https://doi.org/10.1517/13543776.10.12.1843
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in miceGene Therapy, 1998
- Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient miceOncogene, 1998
- Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationNature Genetics, 1997
- Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?The Journal of cell biology, 1996
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of VitronectinPublished by Elsevier ,1996
- The crystal structure of the catalytic domain of human urokinase-type plasminogen activatorStructure, 1995
- Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domainProtein Engineering, Design and Selection, 1995
- Solution Structure of the Amino-Terminal Fragment of Urokinase-Type Plasminogen ActivatorBiochemistry, 1994
- Protein Structure and Membrane Anchorage of the Cellular Receptor for Urokinase-Type Plasminogen ActivatorSeminars in Thrombosis and Hemostasis, 1991